I said this earlier this week: The US needs to get serious about reindustrialization like yesterday, and biomanufacturing needs to be front and center. We are already behind and the lead is widening DAILY.

Charlie , you aren't close. Drug prices are too damn high. But the big culprit isn't the brand manufacturers, it's the big middlemen. Namely PBMs. They work so hard to distort pricing the first lines in their contracts with everyone is "you can't disclose any of this " How bad

Thanks to our keynote speaker Dr. Jake Becraft Jake Becraft for kicking off the Univerity of Delaware's NSF Accelerating Reserch Translation Conference. What a great way to start the day.

It was an incredible opportunity to come speak with aspiring science-entrepreneurs here at the University of Delaware. And getting an invite to keynote from my own undergraduate research mentor, John Slater, was special in its own right!

Still taking it in. This week at #ASCO25, we shared something that once felt impossible: Programmable mRNA driving real tumor responses in patients with few options. This is why we started Strand. Hope is no longer hypothetical. #StrandTx #CancerResearch #mRNA #Oncology

Strand just closed our $153M Series B. It is hard to put into words what it means to see this team and this vision grow from an idea into a company that can truly change medicine. Grateful. Fired up. And ready to build what’s next.